Zhong 5-antibody panel for Lung Cancer
A potential autoantibody profile was developed to screen for non-small cell lung cancer. 212 immunogenic phage-expressed proteins were statistically ranked for their individual reactivity with 23 stage I cancer patient and 23 risk-matched control samples. Measurements of the five most predictive antibody markers in 46 cases and controls were combined. While the identity of these phage-expressed proteins is not critical for use in a diagnostic assay, the identities were determined through a nucleotide search of GenBank. Markers are: paxillin, SEC 15L2, BAC clone RP11-499F19, XRCC5, and MALAT1.
No member markers defined for this panel.
There are no datasets associated with this biomarker.
The following organs have data associated with this biomarker…
Antibody profiling may be a useful tool for early detection of NSCLC.
No associated resources found.